$EYE

National Vision (EYE) reported Q2 results with a 4.9% decline in store traffic but a 2.2% rise in comparable sales and 40% growth in adjusted EPS. CEO Alex Wilkes attributed this to a shift toward higher-value customers and e-commerce initiatives. The company's inventory increased due to store segmentation strategies, and its e-commerce replatform disruption is now resolved. National Vision raised its full-year adjusted operating income outlook and repurchased $20 million in shares.

National Vision Holdings (EYE) reported Q2 2026 net revenue of $498.8M, up 2.5%, with adjusted EPS of $0.25. Adjusted comp sales grew 2.2%, offset by a 4.9% traffic decline due to e-commerce replatforming. The company narrowed its full-year revenue guidance to $2.037B-$2.076B, citing traffic dynamics. Management highlighted a shift toward premium products and cost efficiencies.

EyePoint’s shares fell over 70% after its phase 3 readout for Duravyu, a drug-device combo for wet age-related macular degeneration, missed a primary endpoint versus Regeneron’s Eylea. EyePoint cited non-wAMD related vision loss in 9 of 211 patients and said an ad hoc analysis showed non-inferiority. Lucia trial is due this fall.

National Vision Holdings (Nasdaq: EYE) reported Q2 net revenue up 2.5% to $498.8 million and net income of $12.4 million versus $8.7 million. Diluted EPS rose to $0.15 from $0.11, and adjusted operating income increased 32.7% to $31.6 million. The company raised its 2026 adjusted operating income outlook to $119-$139 million from $107-$133 million.

National Vision (NASDAQ:EYE) reported positive managed-care comparable sales growth, citing traffic and ticket gains and growth in anti-reflective, transition, polycarbonate and premium progressive lenses. The company said e-commerce replatforming reduced adjusted comparable-store sales by about 150 bps in Q2. Outlook: net revenue $2.03B-$2.08B, adjusted comp sales +3%-5%, adjusted operating income $119M-$139M, adjusted EPS $0.94-$1.09.

National Vision Holdings shares rose 1.9% in pre-open trading after the company reported Q2 2026 results. Analysts expected about $0.18 EPS on ~$499.84M revenue, versus Q1 adjusted EPS of $0.45 and 6.6% YoY revenue growth. The firm reaffirmed full-year 2026 EPS guidance of $0.85 to $1.09 and filed an 8-K. The earnings call coincided with the U.S. CPI release.

National Vision Holdings, Inc. (EYE) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 National Vision Holdings, Inc. Reports Second Quarter 2026 Financial Results Strategic Transformation Delivers Accelerated Profitability Raises Full-Year Adjusted Operating Income and Tightens Adjusted Comparable Store Sales Growth Outlook Second quarter 2026 highlig

Itaconix (ITX) raised 2026 revenue guidance to at least $14.8m from $13.3m after H1 revenues rose 72% to $8.3m. It expects 2026 gross margin of 36% and said guidance supports breakeven and investment. Eagle Eye (EYE) reported FY26 results ahead of expectations, with ARR up 31% to £44.5m. Alumasc (ALU) suspended CEO Pamela Bingham and trimmed forecasts.

Eagle Eye Solutions (LON:EYE) shares rose 7.5% after the loyalty and promotions platform provider said it expects a return to double-digit revenue and EBITDA growth in fiscal year 2027. The company attributed the outlook to higher annual recurring revenue and new customer acquisitions, and reiterated targets of over £100 million revenue and EBITDA margin above 30%.

Eagle Eye Solutions said annual recurring revenue rose 31% year over year to £44.5 million for FY2026, driven by new customer contracts and its OEM partnership. Total revenue increased 21% to £46.1 million, excluding a lost NRS contract. Adjusted EBITDA was £9.8 million. FY2027 targets double-digit revenue and EBITDA growth.